Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,89%
1 083,04
-9,76
-0,89%
—1 092,801 093,681 094,851 081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,39%
602,38
-2,36
-0,39%
—604,74604,74605,10601,34——
SIXE
Energy
SIXE
Energy
SIXE
+2,31%
1 242,83
+28,03
+2,31%
—1 214,801 220,811 243,821 220,81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,62%
1 713,82
-10,75
-0,62%
—1 724,571 727,021 732,301 707,43——
SIXM
Financials
SIXM
Financials
SIXM
+0,09%
639,99
+0,56
+0,09%
—639,43641,58644,53637,50——
SIXR
Staples
SIXR
Staples
SIXR
-0,20%
837,46
-1,69
-0,20%
—839,15836,90840,48832,89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,65%
214,22
-1,40
-0,65%
—215,62215,62216,21213,48——
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3 204,38
+24,86
+0,78%
—3 179,523 191,503 205,093 177,75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,23%
925,38
-11,53
-1,23%
—936,91935,42937,17923,20——
SIXV
Health care
SIXV
Health care
SIXV
-0,69%
1 442,71
-10,06
-0,69%
—1 452,771 445,931 447,431 434,91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,16%
2 361,34
-3,84
-0,16%
—2 365,182 353,642 368,102 347,80——
EVO:NASDAQ
Evotec SE
2,94 US$
0,00%
(0,00) 1K
3,00 US$
+2,04% (+0,060)
Birjadan oldin
Savdolar yopilgan: 29-apr, 16:00:00 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
EVO tikeri uchun statistika yaratilmoqda...
Bozor kapitali
1,04 mlrd
Oʻrtacha hajm
119,42 ming
Hajmi
4,16 ming
52 haftalik eng yuqori
4,80 US$
52 haftalik eng past
2,31 US$
Aksiya boʻyicha daromad
-0,34 US$
Beta
1,90
Muomaladagi aksiyalar
355,76 mln
Xodimlar soni
4 ming
Yangiliklar
Internetdagi manbalardan
Profil
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development. The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more. On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
Evotec SE haqida
CEO-
Xodimlar soni4,47 ming
Asos solingan1993
Bosh ofislar-
Sektor-
Veb-saytevotec.com
Oxirgi hisobot
8-apr, 2026
Moliya davri
Ch.4 2025
Normallashtirilgan EPS / Taxminiy
0,04/ -EUR
0,00%manfiy
Daromad / Taxminan
788,37 mln/ (265,56 mln taxm.)EUR
+196,87%musbat
Q4 2025 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
QisqachaOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – EUR
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – EUR
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
199,98 mln
171,24 mln
163,89 mln
253,27 mln
Sotilgan mahsulotning tannarxi
172,75 mln
162,64 mln
163,95 mln
174,81 mln
Daromad narxi
172,75 mln
162,64 mln
163,95 mln
174,81 mln
Tadqiqot va ishlanmalarga xarajatlar
10,76 mln
8,21 mln
8,71 mln
9,83 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
47,70 mln
41,61 mln
42,31 mln
44,35 mln
Operatsion xarajatlar
47,04 mln
37,19 mln
43,53 mln
55,25 mln
Jami operatsion xarajatlar
219,79 mln
199,83 mln
207,48 mln
230,06 mln
Operatsion daromad
-19,82 mln
-28,60 mln
-43,59 mln
23,21 mln
Boshqa nooperatsion daromad
-6,86 mln
-10,64 mln
1,19 mln
-33,96 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-29,85 mln
-43,42 mln
-42,96 mln
29,46 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-29,66 mln
-44,67 mln
-43,36 mln
18,35 mln
Daromad soligʻi boʻyicha xarajat
1,73 mln
59,00 ming
127,00 ming
14,84 mln
Amaldagi soliq stavkasi
-5,78%
-0,14%
-0,30%
50,37%
Boshqa operatsion xarajatlar
-11,41 mln
-12,63 mln
-7,50 mln
1,07 mln
Sof foyda
-31,58 mln
-43,48 mln
-43,09 mln
14,62 mln
Sof foyda marjasi
-15,79%
-25,39%
-26,29%
5,77%
Har bir aksiya foydasi
-
-
-0,24
-
Foizlar va investitsiyalardan olingan daromadlar
-
1,21 mln
841,00 ming
11,84 mln
Foizlarni toʻlash xarajatlari
-2,41 mln
-6,00 mln
-2,28 mln
-
Foizlarni toʻlash boʻyicha sof xarajatlar
-2,41 mln
-4,79 mln
-1,44 mln
11,84 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
76,50 ming
-3,42 mln
-18,27 mln
41,91 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish